Therapeutic Targeting of Hepatic Macrophages for the Treatment of Liver Diseases.


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 27 08 2019
accepted: 20 11 2019
entrez: 19 12 2019
pubmed: 19 12 2019
medline: 5 11 2020
Statut: epublish

Résumé

Hepatic macrophages play a central role in maintaining homeostasis in the liver, as well as in the initiation and progression of liver diseases. Hepatic macrophages are mainly derived from resident hepatic macrophages called Kupffer cells or circulating bone marrow-derived monocytes. Kupffer cells are self-renewing and typically non-migrating macrophages in the liver and are stationed in the liver sinusoids in contrast to macrophages originating from circulating monocytes. Kupffer cells regulate liver homeostasis by mediating immunity against non-pathogenic blood-borne molecules, while participating in coordinated immune responses leading to pathogen clearance, leukocyte recruitment and antigen presentation to lymphocytes present in the vasculature. Monocyte-derived macrophages infiltrate into the liver tissue when metabolic or toxic damage instigates and are likely dispensable for replenishing the macrophage population in homeostasis. In recent years, different populations of hepatic macrophages have been identified with distinct phenotypes with discrete functions, far beyond the central dogma of M1 and M2 macrophages. Hepatic macrophages play a central role in the pathogenesis of acute and chronic liver failure, liver fibrosis, non-alcoholic fatty liver disease, alcoholic liver disease, viral hepatitis, and hepatocellular carcinoma, as well as in disease resolution. The understanding of the role of hepatic macrophages in liver diseases provides opportunities for the development of targeted therapeutics for respective malignancies. This review will summarize the current knowledge of the hepatic macrophages, their origin, functions, their critical role in maintaining homeostasis and in the progression or resolution of liver diseases. Furthermore, we will provide a comprehensive overview of the therapeutic targeting strategies against hepatic macrophages developed for the treatment of liver diseases.

Identifiants

pubmed: 31849997
doi: 10.3389/fimmu.2019.02852
pmc: PMC6901832
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

2852

Informations de copyright

Copyright © 2019 van der Heide, Weiskirchen and Bansal.

Références

PLoS One. 2019 Jul 3;14(7):e0218971
pubmed: 31269038
Front Immunol. 2018 Dec 14;9:2948
pubmed: 30619308
Hepatology. 2012 Mar;55(3):898-909
pubmed: 22031018
Mediators Inflamm. 2015;2015:816460
pubmed: 26089604
Gastroenterology. 2011 Nov;141(5):1572-85
pubmed: 21920463
Cell Physiol Biochem. 2018;51(2):557-574
pubmed: 30458454
PLoS One. 2014 May 14;9(5):e96864
pubmed: 24828436
Hepatology. 2014 May;59(5):2034-42
pubmed: 24115204
Blood. 2005 Nov 1;106(9):3004-11
pubmed: 16020514
Hepatology. 2009 Aug;50(2):612-21
pubmed: 19575456
Cells. 2019 Aug 07;8(8):
pubmed: 31394730
Cell. 2010 Apr 2;141(1):39-51
pubmed: 20371344
J Investig Med. 2016 Aug;64(6):1075-7
pubmed: 27382116
Angew Chem Int Ed Engl. 2006 May 5;45(19):3165-9
pubmed: 16572498
PLoS One. 2016 Jun 27;11(6):e0158156
pubmed: 27347680
Am J Physiol Gastrointest Liver Physiol. 2011 Apr;300(4):G516-25
pubmed: 21252049
Cell. 2019 Apr 18;177(3):541-555.e17
pubmed: 30955887
Biomaterials. 2015 Jan;37:367-82
pubmed: 25453965
Hepatology. 2009 Jul;50(1):261-74
pubmed: 19554540
Cancer Cell. 2004 Mar;5(3):215-9
pubmed: 15050913
Hepatology. 2015 Jul;62(1):279-91
pubmed: 25810240
J Hepatol. 2008 Nov;49(5):845-61
pubmed: 18801592
PLoS One. 2017 Jan 11;12(1):e0169740
pubmed: 28076416
Hepatology. 2018 May;67(5):1754-1767
pubmed: 28833331
F1000Res. 2018 Jun 27;7:null
pubmed: 30002817
Cell Mol Immunol. 2016 May;13(3):316-27
pubmed: 26908374
Hepatology. 2016 Oct;64(4):1057-71
pubmed: 27302565
Nat Immunol. 2013 Oct;14(10):996-1006
pubmed: 24048121
N Engl J Med. 2002 Apr 18;346(16):1221-31
pubmed: 11961152
J Hepatol. 2014 May;60(5):1090-6
pubmed: 24412603
Diabetes. 2010 Feb;59(2):347-57
pubmed: 19934001
J Hepatol. 2014 Sep;61(3):660-71
pubmed: 24798624
Aliment Pharmacol Ther. 2004 Apr 1;19(7):715-27
pubmed: 15043512
J Leukoc Biol. 2007 Sep;82(3):479-87
pubmed: 17595379
PLoS One. 2012;7(8):e42180
pubmed: 22870295
Annu Rev Immunol. 2007;25:745-85
pubmed: 17201678
Semin Cancer Biol. 2011 Feb;21(1):35-43
pubmed: 20946957
J Hepatol. 2019 Sep;71(3):631-633
pubmed: 31213365
Immunity. 2017 Nov 21;47(5):913-927.e6
pubmed: 29150239
Hepatol Commun. 2019 Apr 22;3(6):730-743
pubmed: 31168508
Science. 2016 Sep 9;353(6304):
pubmed: 27492475
Hepatology. 2013 Feb;57(2):577-89
pubmed: 22987396
J Antimicrob Chemother. 2014 Jul;69(7):1903-10
pubmed: 24651825
Gastroenterology. 2015 Dec;149(7):1896-1909.e14
pubmed: 26344055
Hepatology. 2010 Feb;51(2):511-22
pubmed: 20054868
J Clin Invest. 2009 Jul;119(7):1858-70
pubmed: 19603542
Hepatology. 2008 Sep;48(3):799-807
pubmed: 18570214
J Leukoc Biol. 2009 Nov;86(5):1065-73
pubmed: 19741157
J Control Release. 2018 Oct 28;288:227-238
pubmed: 30219279
Hepatology. 2015 Mar;61(3):883-94
pubmed: 25251280
J Hepatol. 2013 Sep;59(3):583-94
pubmed: 23567086
World J Gastroenterol. 2014 Jun 21;20(23):7381-91
pubmed: 24966608
Science. 2006 Jan 6;311(5757):83-7
pubmed: 16322423
Cell. 2016 Apr 21;165(3):668-78
pubmed: 27062926
Front Immunol. 2015 May 19;6:225
pubmed: 26042120
Lab Invest. 2017 Aug;97(8):890-902
pubmed: 28504685
Langmuir. 2007 Apr 24;23(9):4938-43
pubmed: 17375944
J Immunol. 2014 Jul 1;193(1):344-53
pubmed: 24890723
PLoS One. 2016 Jul 25;11(7):e0159524
pubmed: 27454866
Gut. 2017 Jun;66(6):1138-1153
pubmed: 28314735
Gut. 2012 Mar;61(3):416-26
pubmed: 21813474
J Hepatol. 2016 Oct;65(4):758-768
pubmed: 27262757
Development. 1999 Nov;126(22):5073-84
pubmed: 10529424
Diabetologia. 2016 May;59(5):879-94
pubmed: 26940592
Hepatology. 2017 Jan;65(1):376-379
pubmed: 27775816
Semin Liver Dis. 2017 Aug;37(3):189-197
pubmed: 28847030
Hepatology. 2010 Jan;51(1):307-28
pubmed: 20034030
Immunity. 2015 Jan 20;42(1):145-58
pubmed: 25577440
Hepatology. 2014 Mar;59(3):1060-72
pubmed: 24481979
Dig Dis. 2016;34(4):410-22
pubmed: 27170396
Int Immunol. 2018 Oct 29;30(11):493-501
pubmed: 29986024
J Hepatol. 2015 Jul;63(1):114-21
pubmed: 25681553
Biomed Res Int. 2013;2013:187204
pubmed: 23533994
J Hepatol. 2017 Jun;66(6):1300-1312
pubmed: 28267621
Pflugers Arch. 2013 Jun;465(6):775-8
pubmed: 23292551
PLoS One. 2014 Sep 12;9(9):e107265
pubmed: 25216251
J Virol. 2013 Nov;87(22):12284-90
pubmed: 24006444
J Leukoc Biol. 2019 Aug;106(2):345-358
pubmed: 30576000
Nat Rev Gastroenterol Hepatol. 2019 Mar;16(3):145-159
pubmed: 30482910
Hepatology. 2014 Apr;59(4):1564-76
pubmed: 24282114
Ther Deliv. 2012 Apr;3(4):457-78
pubmed: 22834077
Nat Rev Immunol. 2014 Mar;14(3):181-94
pubmed: 24566915
Proc Natl Acad Sci U S A. 2012 Nov 13;109(46):E3186-95
pubmed: 23100531
Semin Liver Dis. 2017 Feb;37(1):1-10
pubmed: 28201843
Metabolism. 2018 Jan;78:80-94
pubmed: 28941597
Immunobiology. 2009;214(9-10):761-77
pubmed: 19616341
Fibrogenesis Tissue Repair. 2012 Jun 06;5(Suppl 1):S27
pubmed: 23259611
J Infect Dis. 2015 Apr 15;211(8):1268-78
pubmed: 25362194
Hepatol Res. 2013 Jun;43(6):658-69
pubmed: 23107150
Nat Rev Cancer. 2005 Mar;5(3):161-71
pubmed: 15738981
Bioconjug Chem. 2010 May 19;21(5):797-802
pubmed: 20397686
Gut. 2019 May 10;:null
pubmed: 31076404
Hepatobiliary Surg Nutr. 2014 Dec;3(6):364-76
pubmed: 25568860
J Exp Med. 2008 Jan 21;205(1):233-44
pubmed: 18195076
Hepatology. 2018 Feb;67(2):549-559
pubmed: 28892558
Nat Commun. 2018 Oct 22;9(1):4383
pubmed: 30348985
PLoS One. 2013 Dec 18;8(12):e83481
pubmed: 24367597
Semin Liver Dis. 2001 Aug;21(3):311-35
pubmed: 11586463
Pflugers Arch. 2017 Apr;469(3-4):553-560
pubmed: 28293730
J Clin Invest. 2016 Mar 1;126(3):859-64
pubmed: 26808498
Nature. 2015 Feb 26;518(7540):547-51
pubmed: 25470051
Chem Res Toxicol. 2002 Dec;15(12):1504-13
pubmed: 12482232
Mol Cell. 2019 Aug 8;75(3):644-660.e5
pubmed: 31398325
Liver Int. 2010 Jul;30(6):782-94
pubmed: 20492514
Clin Sci (Lond). 2012 Oct;123(7):459-71
pubmed: 22545719
J Hepatol. 2018 Apr;68(4):682-690
pubmed: 29274730
Science. 2009 Jul 31;325(5940):612-6
pubmed: 19644120
Mol Aspects Med. 2019 Feb;65:2-15
pubmed: 29958900
Hepatology. 2018 Apr;67(4):1270-1283
pubmed: 28940700
Ann N Y Acad Sci. 2009 Feb;1155:206-21
pubmed: 19250206
Am J Physiol Gastrointest Liver Physiol. 2012 Jun 1;302(11):G1310-21
pubmed: 22442158
Nat Rev Gastroenterol Hepatol. 2016 Feb;13(2):88-110
pubmed: 26758786
Immunity. 2015 Apr 21;42(4):665-78
pubmed: 25902481
Biomaterials. 2013 Apr;34(11):2843-54
pubmed: 23347838

Auteurs

Daphne van der Heide (D)

Department of Biomaterials Science and Technology, Faculty of Science and Technology, Technical Medical Center, University of Twente, Enschede, Netherlands.

Ralf Weiskirchen (R)

Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH University Hospital Aachen, Aachen, Germany.

Ruchi Bansal (R)

Department of Biomaterials Science and Technology, Faculty of Science and Technology, Technical Medical Center, University of Twente, Enschede, Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH